Unichem Laboratories per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹44.01₹35.91₹19.53−₹10.01−₹28.72
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹43.94₹35.85₹19.47−₹10.01−₹28.72
₹386.00₹386.00₹348.10₹335.54₹345.89
₹327.82₹312.76₹299.85₹242.15₹190.75
—₹0.52−₹1.00₹2.37−₹12.09
−₹16.96−₹16.96−₹20.51−₹0.83−₹18.38
—₹0.00₹0.05₹0.03₹4.01
7.07.07.07.07.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

UNICHEMLAB₹488.80

Unichem Laboratories Limited

· Pharma & Health
₹ CrorePeersGUFICBIORPGLIFEGUJTHEMSMSPHARMAORCHPHARMAINDSWFTLABSOLARAFDCMcap ₹3,441 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS-28.72-10.0119.5335.9144.01
Diluted EPS-28.72-10.0119.4735.8543.94
Book Value per Share345.89335.54348.10386.00386.00
Revenue per Share190.75242.15299.85312.76327.82
Cash Flow per Share-12.092.37-1.000.52—
Free Cash Flow per Share-18.38-0.83-20.51-16.96-16.96
Dividends per Share4.010.030.050.00—
Shares Outstanding (cr)7.07.07.07.07.0
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.